Tag Archives: immunogenicity Prediction of Therapeutic Proteins

immuno-screening-mab

Screening for Immunogenicity: Immunotherapy Challenges and Predictive Approaches Applied to Therapeutic Proteins 

As an expert in immunogenicity screening, EpiVax’s CEO/CSO, Dr. Annie De Groot, will be conducting a training on state of the art methods of in silico and in vitro analysis to assess immunogenic risk of therapeutic proteins. Please join us April 5th in … Continue reading

Posted in Events, Featured | Tagged , , , , , , , , , , , | Leave a comment